HC Wainwright & Co. Reiterates Buy on Gritstone Bio, Maintains $7 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Sean Lee has reiterated a 'Buy' rating on Gritstone Bio (NASDAQ:GRTS) and maintained a $7 price target.
August 10, 2023 | 11:51 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Gritstone Bio's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $7.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for investors. The maintained price target of $7 indicates the firm's confidence in the stock's potential to reach this price in the short term. This could lead to increased investor confidence and potential upward movement in the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100